The pharmaceutical industry is anything but stable.
While an aging population and emerging technologies offer an optimistic outlook, downward pressure on pricing and new competition are creating new challenges.
To be successful, companies urgently need to optimize costs and efficiency across operations.
A recent article by McKinsey points out the main strategies implemented by pharma executives over the past decade are simply no longer sufficient.
